Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation

Br J Clin Pharmacol. 2007 Jul;64(1):110-2. doi: 10.1111/j.1365-2125.2006.02840.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Coronary Thrombosis*
  • Humans
  • Paclitaxel / therapeutic use*
  • Risk Factors
  • Sirolimus / therapeutic use*
  • Stents*

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents, Phytogenic
  • Paclitaxel
  • Sirolimus